These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 16537801)

  • 1. MYC levels govern hematopoietic tumor type and latency in transgenic mice.
    Smith DP; Bath ML; Metcalf D; Harris AW; Cory S
    Blood; 2006 Jul; 108(2):653-61. PubMed ID: 16537801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T-cell lymphomas mask slower developing B-lymphoid and myeloid tumours in transgenic mice with broad haemopoietic expression of MYC.
    Smith DP; Bath ML; Harris AW; Cory S
    Oncogene; 2005 May; 24(22):3544-53. PubMed ID: 15688022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated Mcl-1 perturbs lymphopoiesis, promotes transformation of hematopoietic stem/progenitor cells, and enhances drug resistance.
    Campbell KJ; Bath ML; Turner ML; Vandenberg CJ; Bouillet P; Metcalf D; Scott CL; Cory S
    Blood; 2010 Oct; 116(17):3197-207. PubMed ID: 20631380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uncovering MYC's full oncogenic potential in the hematopoietic system.
    Janz S
    Oncogene; 2005 May; 24(22):3541-3. PubMed ID: 15782131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zinc finger protein GFI-1 has low oncogenic potential but cooperates strongly with pim and myc genes in T-cell lymphomagenesis.
    Schmidt T; Karsunky H; Gau E; Zevnik B; Elsässer HP; Möröy T
    Oncogene; 1998 Nov; 17(20):2661-7. PubMed ID: 9840930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predisposition to lymphomagenesis in pim-1 transgenic mice: cooperation with c-myc and N-myc in murine leukemia virus-induced tumors.
    van Lohuizen M; Verbeek S; Krimpenfort P; Domen J; Saris C; Radaszkiewicz T; Berns A
    Cell; 1989 Feb; 56(4):673-82. PubMed ID: 2537153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of Ras, Raf and L-myc but not Bcl-2 family proteins is linked with resistance to TCR-mediated apoptosis and tumorigenesis in thymic lymphomas from TCR transgenic mice.
    Kobzdej M; Matuszyk J; Strzadala L
    Leuk Res; 2000 Jan; 24(1):33-8. PubMed ID: 10634643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transgenic N-myc mouse model for indolent B cell lymphoma: tumor characterization and analysis of genetic alterations in spontaneous and retrovirally accelerated tumors.
    Sheppard RD; Samant SA; Rosenberg M; Silver LM; Cole MD
    Oncogene; 1998 Oct; 17(16):2073-85. PubMed ID: 9798678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VavP-Bcl2 transgenic mice develop follicular lymphoma preceded by germinal center hyperplasia.
    Egle A; Harris AW; Bath ML; O'Reilly L; Cory S
    Blood; 2004 Mar; 103(6):2276-83. PubMed ID: 14630790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Constitutive Bcl-2 expression throughout the hematopoietic compartment affects multiple lineages and enhances progenitor cell survival.
    Ogilvy S; Metcalf D; Print CG; Bath ML; Harris AW; Adams JM
    Proc Natl Acad Sci U S A; 1999 Dec; 96(26):14943-8. PubMed ID: 10611317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Moloney murine leukemia virus infection accelerates lymphomagenesis in E mu-bcl-2 transgenic mice.
    Shinto Y; Morimoto M; Katsumata M; Uchida A; Aozasa K; Okamoto M; Kurosawa T; Ochi T; Greene MI; Tsujimoto Y
    Oncogene; 1995 Nov; 11(9):1729-36. PubMed ID: 7478600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of lymphomagenic oncogenes in T-cell lymphomas of HPV 16 transgenic mice.
    Yang JT; Liu CZ; Domer P; Iannaccone P
    Cancer Detect Prev; 1998; 22(5):405-15. PubMed ID: 9727621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis.
    Eischen CM; Weber JD; Roussel MF; Sherr CJ; Cleveland JL
    Genes Dev; 1999 Oct; 13(20):2658-69. PubMed ID: 10541552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of Vav-promoter-driven overexpression of BCLX and BFL1 on lymphocyte survival and B cell lymphomagenesis.
    Tuzlak S; Haschka MD; Mokina AM; Rülicke T; Cory S; Labi V; Villunger A
    FEBS J; 2018 Apr; 285(8):1403-1418. PubMed ID: 29498802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retroviral infection accelerates T lymphomagenesis in E mu-N-ras transgenic mice by activating c-myc or N-myc.
    Haupt Y; Harris AW; Adams JM
    Oncogene; 1992 May; 7(5):981-6. PubMed ID: 1570158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wild-type p53-triggered apoptosis is inhibited by bcl-2 in a v-myc-induced T-cell lymphoma line.
    Wang Y; Szekely L; Okan I; Klein G; Wiman KG
    Oncogene; 1993 Dec; 8(12):3427-31. PubMed ID: 8247547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High frequency of myelomonocytic tumors in aging E mu L-myc transgenic mice.
    Möröy T; Fisher PE; Lee G; Achacoso P; Wiener F; Alt FW
    J Exp Med; 1992 Feb; 175(2):313-22. PubMed ID: 1310099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A full-length Cbfa1 gene product perturbs T-cell development and promotes lymphomagenesis in synergy with myc.
    Vaillant F; Blyth K; Terry A; Bell M; Cameron ER; Neil J; Stewart M
    Oncogene; 1999 Nov; 18(50):7124-34. PubMed ID: 10597314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2.
    Strasser A; Harris AW; Bath ML; Cory S
    Nature; 1990 Nov; 348(6299):331-3. PubMed ID: 2250704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenous bcl-2 is not required for the development of Emu-myc-induced B-cell lymphoma.
    Kelly PN; Puthalakath H; Adams JM; Strasser A
    Blood; 2007 Jun; 109(11):4907-13. PubMed ID: 17317859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.